Aripiprazole Augmentation of Antidepressants in PTSD

Completed · Phase 2 · Has a placebo group

Conditions studied: PTSD

In brief

The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.

Key facts

Study ID

NCT00489866

Run by

Durham VA Medical Center

People needed

14

Starts

2007-03-01

Expected to finish

2014-12-01

Last updated by the study team

2015-03-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Outpatient veterans with posttraumatic stress disorder (PTSD)
• Receiving treatment with an antidepressant at a stable dose for 4 weeks
• Male or female
• Ages 18-65 years old

Where it is running

• Durham VAMC 508 Fulton Street — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.